Targeting the IL33-NLRP3 axis improves therapy for experimental cerebral malaria. (2018)

First Author: Strangward P


No abstract provided

Bibliographic Information

Digital Object Identifier:

PubMed Identifier: 29954866

Publication URI:

Type: Journal Article/Review

Volume: 115

Parent Publication: Proceedings of the National Academy of Sciences of the United States of America

Issue: 28

ISSN: 0027-8424